Arthritis and pain. Future targets to control osteoarthritis pain

Arthritis Research and Therapy

Volumn 9, Issue 3, 2007, Pages

  Dray, Andy ^a   Read, Simon J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; [8 (3,3 DIPHENYLPROPYL) 4 OXO 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DEC 3 YL]ACETIC ACID; ADL 5859; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; BRADYZIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CELECOXIB; DELTA OPIATE RECEPTOR AGONIST; DEXANABINOL; DRONABINOL; GW 405833; GW 406381; ICATIBANT; LUMIRACOXIB; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE DERIVATIVE; OPIATE RECEPTOR; PARACETAMOL; PLACEBO; ROFECOXIB; SSR 240612; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; BONE PAIN; CANCER PAIN; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; EUPHORIA; HUMAN; NERVE CELL EXCITABILITY; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PAIN; POSTOPERATIVE PAIN; RECEPTOR BINDING; REVIEW; RHEUMATOID ARTHRITIS; SEDATION; SIDE EFFECT; ANIMAL; ARTHRALGIA; PATHOPHYSIOLOGY;

ANIMALS; ARTHRALGIA; HUMANS; OSTEOARTHRITIS;

EID: 35248867194     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2178     Document Type: Review

References (176)

1. Bellamy N Sothern RB Campbell J Rhythmic variations in pain perception in osteoarthritis of the knee J Rheumatol 1990, 17:364-372 2332859
2. Bellamy N Sothern RB Campbell J Buchanan WW Rhythmic variations in pain, stiffness and manual dexterity in hand osteoarthritis Ann Rheum Dis 2002, 61:1075-1080 1753960 12429538 10.1136/ard.61.12.1075
3. Creamer P Hunt M Dieppe P Pain mechanisms in osteoarthritis of the knee: Effect of intra-articular anaesthetic J Rheumatol 1996, 23:1031-1036 8782136
4. Crawford RW Gie GA Ling RS Murray DW Diagnostic value of intra-articular anaesthetic in primary osteoarthritis of the hip J Bone Joint Surg Br 1998, 80:279-281 9546460 10.1302/0301-620X.80B2.8299
5. Kosek E Ordeberg G Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief Pain 2000, 88:69-78 10.1016/S0304-3959(00)00310-9 11098101
6. Buffington ALH Hanlon CA McKeown MJ Acute and persistent pain modulation of attention-related anterior cingulated fMRI activations Pain 2005, 113:172-184 10.1016/j.pain.2004.10.006 15621378
7. Rowbotham MC Kidd BL Porreca F Role of central sensitization in chronic pain: Osteoarthritis and rheumatoid arthritis compared to neuropathic pain Proceedings of the 11th World Congress on Pain. August 21 - 26th 2005, Sydney, Australia Seattle; IASP Press Flor H, Kalso E, Dostrovsky J 2006
8. Fraenkel M Bogardus ST Concato J Wittink DR Treatment options in knee OA Arch Intern Med 2004, 164:1299-1304 10.1001/archinte.164.12.1299 15226163
9. Yaksh TL Pharmacology and mechanisms of opioid analgesic activity Acta Anaesthesiol Scand 1997, 41: 94-111 9061092
10. Hurley RW Hammond DL The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation J Neurosci 2000, 20:1249-1259 10648729
11. Sawynok J Topical and peripherally acting analgesics Pharmacol Rev 2003, 55:1-20 10.1124/pr.55.1.1 12615951
12. Likar R Schafer M Paulak F Sittl R Pipam W Schalk H Geissler D Bernatzky G Intraarticular morphine analgesia in chronic pain patients with osteoarthritis Anesth Analg 1997, 84:1313-1317 10.1097/ 00000539-199706000-00025 9174312
13. Menendez L Lastra A Meana A Hidalgo A Baamonde A Analgesic effects of loperamide in bone cancer pain in mice Pharmacol Biochem Behav 2005, 81:114-121 10.1016/j.pbb.2005.02.007 15894068
14. Whiteside GT Boulet JM Walker K The role of central and peripheral mu opioid receptors in inflammatory pain and edema: A study using morphine and DiPOA
15. Dray A Alternatives to mu-opioid analgesics: Delta-opioid and galanin-receptor selective compounds Progress in Pain Research and Management Seattle: IASP Press Kalso E, McQuay HJ, Wiesenfeld-Hallin Z 1999, 269-280
16. Cahill CM Morinville A Lee M-C Vincent J-P Collier B Beaudet A Prolonged morphine treatment targets δ opioid receptors to neuronal plasma membranes and enhances δ-mediated antinociception J Neurosci 2001, 21:7598-7607 11567050
17. Koblish M LaBuda CJ Ajello CW Gu M Zhou QJ Tuthill PA Chu G Le Bourdonnec B Dolle RE Little PJ Anti-hyperalgesic activity of a novel delta-opioid receptor agonist Soc Neurosci Abst 2005, 490.14
18. Dray A Kinins and their receptors in hyperalgesia Can J Physiol Pharmacol 1997, 75:704-712 9276152 10.1139/cjpp-75-6-704
19. Dray A Perkins MN Bradykinin and inflammatory pain Trends Neurosci 1993, 16:99-104 10.1016/0166-2236(93)90133-7 7681240
20. Wotherspoon G Winter J Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system Neurosci Lett 2000, 294:175-178 11072143 10.1016/S0304-3940(00)01561-5
21. Shughrue PJ Ky B Austin CP Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: An in situ hybridization study J Comp Neurol 2003, 465:372-384 12966562 10.1002/cne.10846
22. Levy D Zochodne DW Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain Pain 2000, 86:265-271 10.1016/ S0304-3959(00)00256-6 10812256
23. Fox A Wotherspoon G McNair K Hudson L Patel S Gentry C Winter L Regulation and function of spinal and peripheral neuronal B(1) bradykinin receptors in inflammatory mechanical hyperalgesia Pain 2003, 104:683-691 10.1016/S0304-3959(03)00141-6 12927641
24. Ferreira J Beirith A Mori MAS Araujo RC Bader M Pesqero JB Calixto JB Reduced nerve injury induced neuropathic pain in kinin B1 receptor knock-out mice J Neurosci 2005, 25:2405-2412 10.1523/ JNEUROSCI.2466-04.2005 15745967
25. Eisenbarth H Rukwied R Petersen M Schmelz M Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin Pain 2004, 110:197-204 10.1016/j.pain.2004.03.031 15275768
26. Vellani V Zachrisson O McNaughton PA Functional bradykinin B1 receptors are expressed in nociceptive neurons and are upregulated by the neurotrophin GDNF J Physiol 2004, 560:391-401 1665249 15319421 10.1113/ jphysiol.2004.067462
27. Marceau F Hess JF Bachvarov DR The B1 receptors for kinins Pharmacol Rev 1998, 50:357-386 9755287
28. Liang YF Haake B Reeh PW Sustained sensitization and recruitment of rat cutaneous nociceptors by bradykinin and a novel theory of its excitatory action J Physiol 2001, 532:229-239 10.1111/j.1469-7793.2001.0229g.x 11283237
29. Fox A Kaur S Li B Panasar M Saha U Davis C Dragoni I Colley S Ritchie T Bevan S Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor Br J Pharmacol 2005, 144:889-899 10.1038/sj.bjp.0706139 15685199
30. Stewart JM Bradykinin antagonists: Discovery and development Peptides 2004, 25:527-732 10.1016/j.peptides.2003.10.016 15134872
31. Burgess GM Perkins MN Rang HP Campbell EA Browen MC McIntyre P Urban L Dziadulewicz EK Ritchie TJ Hallet A Bradyzide, a potent nonpeptide B2 bradykinin receptors antagonist with long lasting oral activity in animal models of inflammatory hyperalgesia Br J Pharmacol 2000, 129:77-86 10.1038/sj.bjp.0703012 10694205
32. Gougat J Ferrari B Lionel S Planchenault C Poncelet M Maruani J Alonso R Cudennec A Croci T Guagnini F SSR240612
33. Gabra BH Sirois P Beneficial effects of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-953, in attenuating streptozotocin-diabetic thermal hyperalgesia Peptides 2003, 24:1131-1139 10.1016/j.peptides.2003.06.003 14612183
34. Flechtenmacher J Talke M Veith D Heil K Gebauer A Schoenharting M Icatibant induces pain relief in patients with osteoarthritis of the knee Proceedings of the 9th World Congress of the OsteoArthritis Research Society Internation (OARSI). Chicago 12 P332 December 2-5 2004
35. Fox A Bevan S Therapeutic potential of cannabinoid receptor agonists as analgesic agents Expert Opin Investig Drugs 2005, 14:695-703 10.1517/ 13543784.14.6.695 16004597
36. Rice ASC Farquhar-Smith WP Nagy I Endocannabinoids and pain: Spinal and peripheral analgesia in inflammation and neuropathy Prostaglandins Leukot Essent Fatty Acids 2002, 66:243-256 10.1054/plef.2001.0362 12052040
37. Mbvundula EC Bunning RA Rainsford KD Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in vitro J Pharm Pharmacol 2006, 58:351-358 10.1211/jpp.58.3.0009 16536902
38. Kreitzer Ac Regeher WG Retrograde signaling by endocannabinoids Curr Opin Neurobiol 2002, 12:324-330 10.1016/S0959-4388(02)00328-8 12049940
39. de Novellis V Mariani L Palazzo E Vita D Marabese I Scafuro M Rossi F Maione S Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat Neuroscience 2005, 134:269-281 10.1016/j.neuroscience.2005.03.014 15953687
40. Walker JM Huang SM Strangman NM Tsou K Sanudo-Pena MC Pain modulation by release of the endogenous cannabinoid anandamide Proc Natl Acad Sci USA 1999, 96:12198-12203 18435 10518599 10.1073/pnas.96.21.12198
41. Campbell FA Tramer MR Carroll D Reynolds DJ Moore RA McQuay HJ Are cannabinoids an effective and safe treatment option in the management of pain? A quantitative systematic review BMJ 2001, 323:13-16 34324 11440935 10.1136/bmj.323.7303.13
42. Dyson A Peacock M Chen A Courade J-P Yaqoob Groark A Brain C Loong Y Fox A Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat Pain 2005, 116:129-137 10.1016/j.pain.2005.03.037 15936883
43. Richardson JD Kilo S Hargreaves KM Cannabinoids reduce hyperalgesia and inflammation via interactions with peripheral CB1 receptors Pain 1998, 75:111-119 10.1016/S0304-3959(97)00213-3 9539680
44. Karst M Salim K Burstein S Conrad I Hoy L Schneider U Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: A randomized controlled trial JAMA 2003, 290:1757-1762 10.1001/ jama.290.13.1757 14519710
45. Malan TP Ibrahim MM Lai J Vanderah TW Makriyannis A Porreca F CB2 cannabinoid receptor agonists: Pain relief without psychoactive effects? Curr Opin Pharmacol 2003, 3:62-67 10.1016/S1471-4892(02)00004-8 12550743
46. Labuda CJ Koblish M Little PJ Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain Eur J Pharmacol 2005, 527:172-175 10.1016/j.ejphar.2005.10.020 16316653
47. Valenzano KJ Tafesse L Lee G Harrison JE Bulet JM Gottshall SL Mark L Pearson MS Miller W Shan S Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy Neuropharmacology 2005, 48:658-672 10.1016/ j.neuropharm.2004.12.008 15814101
48. Elmes SJR Winyard LA Medhurst A Clayton SJ Wilson NM Kendall AW Chapman V Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat Pain 2005, 118:327-335 10.1016/j.pain.2005.09.005 16289798
49. Sokal DM Elmes SJR Kendall DA Chapman V Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurons via activation of Cb2 receptors in anaesthetized rats Neuropharmacology 2003, 45:404-411 10.1016/S0028-3908(03)00195-3 12871657
50. Cravatt BF Lichtman AH The endogenous cannabinoid system and its role in nociceptive behavior J Neurobiol 2004, 61:149-160 10.1002/neu.20080 15362158
51. Cravatt BF Demarest K Patricelli MP Bracey MH Giang DK Martin BR Lichtman AH Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolyse Proc Natl Acad Sci USA 2001, 98:9371-9376 55427 11470906 10.1073/ pnas.161191698
52. Lichtman AH Leung D Shelton CC Saghatelian A Hardouin C Boger DL Cravatt BJ Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity J Pharmacol Exp Ther 2004, 311:441-448 10.1124/ jpet.104.069401 15229230
53. Chang L Luo L Palmer JA Sutton S Wilson SJ Barbier AJ Breitenbucher JG Chaplan SR Webb M Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms Br J Pharmacol 2006, 148:102-113 10.1038/sj.bjp.0706699 16501580
54. Cichewicz DL McCarthy EA Antinociceptive synergy between D9 tetrahydrocannabinol and opioids after oral administration J Pharmacol Exp Ther 2003, 304:1010-1015 10.1124/jpet.102.045575 12604676
55. England S Bevan S Dougherty RJ PGE2 modulate the tetrodotoxin-resistant sodium current in neonatal dorsal root ganglion neurons via the cyclic AMP-protein kinase A cascade J Physiol 1996, 495:429-440 1160802 8887754
56. Gold MS Levine JD Correa M Modulation of TTX-R I Na by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro J Neurosci 1998, 18:10345-10355 9852572
57. Bar K-J Natura G Telleria-Diaz A Tascher P Vogel R Vasques E Schaible H-G Ebersberger A Changes in the effect of spinal prostaglandin E2 during inflammation: Prostaglandin E9EP1-EP4) receptors in spinal nociceptive processing of input from the normal and inflamed knee joint J Neurosci 2004, 24:642-651 10.1523/JNEUROSCI.0882-03.2004 14736850
58. Yaksh TL Dirig DM Conway CM Svensson C Luo ZD Isakson PC The acute hyperalgesic action of non-steroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1 J Neurosci 2001, 21:5847-5853 11487607
59. Harvey RJ Depner UB Wassle H Ahmadi S Heidl C Reinold H Smart TG Harvey K Schultz B Abo-Salem OM Gly α3: An essential target for spinal PGE2-mediated inflammatory pain sensitization Science 2004, 304:884-887 10.1126/science.1094925 15131310
60. Chandrasekharan NV Dai H Roos KLT Evanson NK Tomsik J Elton TS Simmons DL COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression Proc Natl Acad Sci USA 2002, 99:13926-13931 129799 12242329 10.1073/ pnas.162468699
61. Mitchell JA Warner TD COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs Nat Rev Drug Discov 2006, 5:75-85 10.1038/nrd1929 16485347
62. Jakobsson PJ Thoen S Morgenstern R Samuelsson B Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target Proc Natl Acad Sci USA 1999, 96:7220-7225 22058 10377395 10.1073/pnas.96.13.7220
63. Claveau D Sirinyan M Guay J Gordon R Chan C-C Bureau Y Riendeau D Mancini JA Microsomal prostaglandin synnthase-1 is a major terminal synthase that is selectively upregulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-arthritis model J Immunol 2003, 170:4738-4744 12707354
64. Trebino CE Stock JL Gibbons CP Naiman BM Wachtmann TS Umland JP Pandher K Lapointe JM Saha S Roach ML Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase Proc Natl Acad Sci USA 2003, 100:9044-9049 166435 12835414 10.1073/pnas.1332766100
65. Sommer C Kress M Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia Neurosci Lett 2004, 361:184-187 10.1016/j.neulet.2003.12.007 15135924
66. Ohtori S Takahashi K Moriya H Myers RR TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord Spine 2004, 29:1082-1088 10.1097/ 00007632-200405150-00006 15131433
67. Pollock J McFarlane SM Connell MC Zehavi U Vandenabeele P MacEwan DJ Scott RH TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurons Neuropharmacology 2002, 42:93-106 10.1016/S0028-3908(01)00163-0 11750919
68. Schafers M Marziniak M Sorkin LS Yaksh TL Sommer C Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat Exp Neurol 2004, 185:160-168 10.1016/j.expneurol.2003.09.015 14697327
69. Schafers M Sorkin LS Geis C Shubayev VI Spinal ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia of rat Neurosci Lett 2003, 347:179-182 10.1016/S0304-3940(03)00695-5 12875915
70. Grunke M Schulze-Koops H Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade Ann Rheum Dis 2006, 65:555-556 10.1136/ard.2006.053272 16531556
71. Watkins LR Maier S Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states Physiol Rev 2002, 82:981-1011 12270950
72. Zhang N Inan S Cowan A Sun R Wang JM Rogers TJ Caterina M Oppenheim JJ A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1 Proc Natl Acad Sci USA 2005, 102:4536-4541 555471 15764707 10.1073/pnas.0406030102
73. Oh SB Tran PB Gillard SE Hurley RW Hammond DL Miller RJ Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons J Neurosci 2001, 21:5027-5035 11438578
74. Weidler C Holzer C Harbuz M Hofbauer R Angele P Scholmerich J Straub RH Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium Ann Rheum Dis 2005, 64:13-20 10.1136/ard.2003.016154 15608299
75. Miller LE Wiedler C Falk W Angele P Schaumberger J Scholmerich J Straub R Increased prevalence of semaphorin3C, a repellent of sympathetic nerve fibres in synovial tissue of patients with rheumatoid arthritis Arthritis Rheum 2004, 50:1156-1163 10.1002/art.20110 15077297
76. Niissalo S Hukkanen M Imai S Tornwall J Konttinen YT Neuropeptides in experimental and degenerative arthritis Ann N Y Acad Sci 2002, 966:384-399 12114296
77. Zhang JM LI H Munir MA Decreasing sympathetic sprouting in pathological sympathetic ganglia: A new mechanism for treating neuropathic pain using lidocaine Pain 2004, 109:143-149 10.1016/j.pain.2004.01.033 15082136
78. Shinder V Govrin-Lippmann R Cohen S Belenky M Ilin P Fried K Wilkinson HA Devor M Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury J Neurocytol 1999, 28:743-761 10.1023/A:1007090105840 10859576
79. Sato J Perl ER Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury Science 1991, 251:1608-1610 10.1126/ science.2011742 2011742
80. Lee DH Liu X Kim HT Chung K Chung JM Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats J Neurophysiol 1999, 81:2226-2233 10322061
81. Ali Z Raja SN Wesselmann U Fuchs PN Meyer RA Campbell JN Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain Pain 2000, 88:161-168 10.1016/S0304-3959(00)00327-4 11050371
82. McNearney T Baethge BA Cao S Alam R Lisse JR Westlund KN Excitatory amino acids, TNFα and chemokine levels in synovial fluids of patients with active arthropathies Clin Exp Immunol 2004, 137:621-627 10.1111/j.1365-2249.2004.02563.x 15320917
83. Neugebauer V Glutamate receptor ligands Handb Exp Pharmacol 2007, 177:217-249 17087125
84. Szekely JI Torok K Mate G The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites Curr Pharm Des 2002, 8:887-912 11945138 10.2174/1381612024607126
85. Merle B Itzstein C Delmas PD Chenu C NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis J Cell Biochem 2003, 90:424-436 10.1002/jcb.10625 14505357
86. Salter DM Wright MO Millward-Sadler SJ NMDA receptor expression and roles in human articular chondrocyte mechanotransduction Biorheology 2004, 41:273-281 15299260
87. Danysz W Parsons CG GlycineB recognition site of NMDA receptors and its antagonists Amino Acids 1998, 14:205-206 10.1007/BF01345263 9871462
88. Quartaroli M Fasdelli N Bettelini L Maraia G Corsi M GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice Eur J Pharmacol 2001, 430:219-227 10.1016/S0014-2999(01)01278-X 11711034
89. Wallace MS Rowbotham MC Katz NP Dworkin RH Dotson RM Galer BS Rauck RL Backonja MM Quessy SN Meisner PD A randomized, double blind, placebo-controlled trial of a glycine antagonist in neuropathic pain Neurology 2002, 59:1694-1700 12473754
90. Taniguchi K Shinjo K Mizutani M Shimada K Ishikawa T Menniti F Nagahisa A Antinociceptive actions of CP-101,606, an NMDA receptor NR2B subunit antagonist Br J Pharmacol 1997, 122:809-812 9384494 10.1038/ sj.bjp.0701445
91. Hudson LJ Bevan S McNair K Gentry C Fox A Kuhn R Winter J Metabotropic glutamate receptor 5 up-regulation in A-fibers after spinal nerve injury: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia J Neurosci 2002, 22:2660-2668 11923431
92. Dogrul A Ossipov MH Lai J Malan TP Porecca F Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGluR5) antagonist, in experimental neuropathic pain in rats Neurosci Lett 2000, 292:115-118 10998562 10.1016/S0304-3940(00)01458-0
93. Zhu CZ Wilson SG Mikusa JP Wismer CT Gauvin DM Lynch JJ 3rd Wade CL Decker MW Honore P Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities Eur J Pharmacol 2004, 506:107-118 10.1016/j.ejphar.2004.11.005 15588730
94. Boxall SJ Berthele A Laurie DJ Sommer B Zieglgansberger W Urban L Tolle TR Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation Neuroscience 1998, 82:591-602 10.1016/ S0306-4522(97)00246-7 9466463
95. Chiechio S Caricasole A Barletta E Storto M Catania MV Copani A Vertechy M Nicolai R Calvani M Melchiorri D Nicoletti F L-Acetylcarnitine induces analgesia by selectively upregulating mGlu2 metabotropic glutamate receptors Mol Pharmacol 2002, 61:989-996 11961116 10.1124/mol.61.5.989
96. Vellani V Mappleback S Moriondo A Davis JB McNaughton PA Protein kinase C activation gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide J Physiol 2001, 534:813-825 10.1111/ j.1469-7793.2001.00813.x 11483711
97. Szallasi A Blumberg PM Vanilloid (Capsaicin) receptors and mechanisms Pharmacol Rev 1999, 51:159-212 10353985
98. Cantillon M Vause E Sykes D Moon A Hughes S Safety, tolerability and efficacy of ALGRX 4975 in osteoarthritis (OA) of the knee Journal of Pain 2005, 6(3):S39
99. Garcia-Martiez C Humet M Planells-Casas R Gomis A Capri M Viaa F de la Pena E Sachez-Baez F Carbonell T de Felipe C Attenuation of thermal nociception and hyperalgesia by VR1 blockers Proc Natl Acad Sci USA 2002, 99:2374-2379 122372 11854530 10.1073/pnas.022285899
100. Gavva NR Tamir R Qu Y Klionsky L Zhang TJ Immke D Wang J Zhu D Vanderah TW Porreca F Doherty EM AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties J Pharmacol Exp Ther 2005, 313:474-484 10.1124/jpet.104.079855 15615864
101. Chizh B Napolitano A O'Donnell M Wang J Brooke A Lai R Aylott M Bullman J Gray E Williams P Appleby J The TRPV1 antagonist SB705498 attenuates TRPV1 receptor mediated activity and inhibits inflammatory hyperalgesia in humans: Results from a Phase 1 study Journal of Pain 2006, 7(4):S42
102. Bandell M Story GM Hwang SW Viswanath V Eid SR Petrus MJ Earley TJ Pataapouian A Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin Neuron 2004, 41:849-853 10.1016/ S0896-6273(04)00150-3 15046718
103. Bland-Ward PA Humphrey PP P2x receptor mediated ATP-induced primary nociceptive neurone activation J Auton Nerv Syst 2000, 81:146-151 10869713 10.1016/S0165-1838(00)00122-3
104. Honore P Kage K Mikusa J Watt AT Johnston JF Wyatt JR Faltynek CR Jarvis MF Lynch K Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats Pain 2002, 99:11-19 10.1016/S0304-3959(02)00032-5 12237180
105. Jarvis MF Burgard EC McGaraughty S Honore P Lynch K Brennan TJ Subieta A van Biesen T Cartmell J Bianchi B A-317491, a novel potent and selective non nucleotide antagonist of P2X(3) and P2X(2/3) receptors, reduces chronic inflammatory and neuropathic pain in the rat Proc Natl Acad Sci USA 2002, 99:17179-17184 139289 12482951 10.1073/pnas.252537299
106. Tsuda M Shigemoto-Mogami Y Koizumi S Mizokoshi A Kohsaka S Salter MW Inoue K P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 2003, 424:778-783 10.1038/ nature01786 12917686
107. Deuchars SA Atkinson L Brooke RE Musa H Milligan CJ Batten TFC Buckley NJ Parson SH Deuchars J Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems J Neurosci 2001, 21:7143-7152 11549725
108. Chessell IP Hatcher JP Bountra C Michel AD Hughes JP Green P Egerton J Murfin M Richardson J Peck WL Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain Pain 2005, 114:386-396 10.1016/j.pain.2005.01.002 15777864
109. Chaplan SR Guo H-Q Lee DH Luo L Liu C Kuei C Velumian AAL Butler MP Brown SM Dubin AE Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain J Neurosci 2003, 23:1169-1178 12598605
110. Yao H Donnelly DF Ma C LaMotte RH Upregulation of the hyperpolarization activation cation current after chronic compression of the dorsal root ganglion J Neurosci 2003, 23:2069-2074 12657665
111. Giatromanolaki A Sivridis E Maltezos E Athanassou N Papazoglou D Gatter KC Harris AL Koukourakis MI Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis Arthritis Res Ther 2003, 5:R193-201 165055 12823854 10.1186/ar756
112. Leffler A Monter B Koltzenburg M The role of the capsaicin receptor TRPV1 and acid sensing ion channels (ASICs) in proton sensitivity of subpopulation of primary nociceptive neurons in rats and mice Neuroscience 2006, 139:699-709 10.1016/j.neuroscience.2005.12.020 16515841
113. Dube GR Lehto SG Breese NM Baker SJ Wang X Matulenko MA Honore P Stewart AO Moreland RB Brioni JD Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels Pain 2005, 117:88-96 10.1016/j.pain.2005.05.021 16061325
114. Matzner O Devor M Hyperexcitability at sites of nerve injury depends on voltage sensitive sodium channels J Neurophysiol 1994, 72:349-359 7965019
115. Eglen RM Hunter JC Dray A Ions in the fire: Recent ion-channel research and approaches to pain therapy Trends Pharmacol Sci 1999, 8:337-342 10.1016/S0165-6147(99)01372-3 10431213
116. Devor M Sodium channels and mechanisms of neuropathic pain Pain 2005, 7(Suppl 1):S3-S12
117. Waxman SG Dib-Hajj S Erythermalgia: Molecular basis for an inherited pain syndrome Trends Mol Med 2005, 11:555-562 10.1016/ j.molmed.2005.10.004 16278094
118. Gould HJ 3rd England JD Soignier RD Nolan P Minor LD Liu ZP Levinson SR Paul D Ibuprofen blocks changes in NaV1.7 and 1.8 sodium currents associated with complete Freunds adjuvant induced inflammation in rat Pain 2004, 5:270-280 10.1016/j.jpain.2004.04.005
119. Araujo MC Sinnott CJ Strichartz GR Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: Responses to early and late infusions Pain 2003, 103:21-29 10.1016/ S0304-3959(02)00350-0 12749955
120. Kastrup J Petersen P Dejgard A Angelo FR Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy Pain 1987, 28:69-75 10.1016/0304-3959(87)91061-X 3822496
121. Okuse K Malik-Hall M Baker MD Poon W-YL Chao MV Wood JN Annexin II light chain regulates sensory neurone-specific sodium channel expression Nature 2002, 417:653-656 10.1038/nature00781 12050667
122. Rush AM Craner MJ Kageyama T Dib-Haj SD Waxman SG Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons Eur J Neurosci 2005, 22:39-49 10.1111/j.1460-9568.2005.04186.x 16029194
123. Yaksh TL Calcium channels as therapeutic targets in neuropathic pain J Pain 2006, 7(1 Suppl 1):S13-S30 16426997 10.1016/j.jpain.2005.09.007
124. Altier C Khosravani H Evans RM Hameed S Peloquin JB Vartian BA Chen L Beedle AM Ferguson SS Mezghrani A ORL-1 receptor mediated internalization of N-type calcium channels Nat Neurosci 2005, 9:31-40 10.1038/nn1605 16311589
125. Kim C Jun K Lee T Kim SS McEnery MW Chin H Kim HL Park JM Kim DK Jung SJ Kim J Shin HS Altered nociceptive response in mice deficient in the α(1B) subunit of the voltage-dependent calcium channel Mol Cell Neurosci 2001, 18:235-245 10.1006/mcne.2001.1013 11520183
126. Saegusa H Kurihara T Zong S Kazuno A Matsuda Y Nonaka T Han W Toriyama H Tanabe T Suppression of inflammation and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel EMBO J 2001 20 2349 2356 125247 11350923 10.1093/emboj/20.10.2349
127. Xiao WH Bennett GJ Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats J Pharmacol Exp Ther 1995, 274:666-672 7636726
128. Snutch TP Targeting chronic and neuropathic pain: The N-type calcium channel comes of age NeuroRx 2005, 2:662-670 1201323 16489373 10.1602/ neurorx.2.4.662
129. Ikeda H Heinke B Ruscheweyh R Sandkuhler J Synaptic plasticity in spinal lamina 1 projection neurons that mediate hyperalgesia Science 2003, 299:1237-1240 10.1126/science.1080659 12595694
130. Matthews EA Dickenson AH Effects of spinally delivered N-and P-type voltage dependent calacium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy Eur J Pharmacol 2001, 415:141-149 10.1016/S0014-2999(01)00812-3 11274992
131. Flatters SJ Bennett GJ Ethosuximaide reverses paclitaxel and vincristine-induced painful peripheral neuropathy Pain 2004, 109:150-161 10.1016/j.pain.2004.01.029 15082137
132. Lu Y Westlund KN Gabapentin attenuates nociceptive behaviours in an acute arthritis model in rats J Pharmacol Exp Ther 1999, 290:214-219 10381778
133. Luo ZD Calcutt NA Higuera ES Valder CR Song YH Svensson CI Myers RR Injury type-specific calcium channel alpha (2) delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin J Pharmacol Exp Ther 2002, 303:1199-1205 10.1124/jpet.102.041574 12438544
134. Jaffe M Iacobellis D Young JP Post-hoc results show beneficial effects of pre-gabalin in patients with osteoarthritis of the hip Arthritis Rheum 2000, 43(Suppl):S337
135. Sah DWY Ossipov MH Porecca F Neurotrophic factors as novel therapeutics for neuropathic pain Nat Rev Drug Discov 2003, 2:460-472 10.1038/nrd1107 12776221
136. Zweifel LS Kuruvilla R Ginty DD Functions and mechanisms of retrograde neurotrophin signaling Nat Rev Neurosci 2005, 6:615-625 10.1038/nrn1727 16062170
137. Lu B Pang PT Woo NH The Yin and Yang of neurotrophin action Nat Rev Neurosci 2005, 6:603-614 16062169 10.1038/nrn1726
138. Ro LS Chen ST Tang LM Jacobs JM Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve Pain 1999, 79:265-274 10.1016/S0304-3959(98)00164-X 10068172
139. Theodosiou M Rush RA Zhou XF Hu D Walker JS Tracey DJ Hyperalgesia due to nerve damage: Role of nerve growth factor Pain 1999, 81:245-255 10.1016/S0304-3959(99)00018-4 10431712
140. Hefti FF Rosenthal A Walicka PA Wyatt S Vergara G Shelton DL Davis AM Novel class of pain drug based on antagonism of NGF Trends Pharmacol Sci 2005, 27:85-91 10.1016/j.tips.2005.12.001 16376998
141. Ji RR Samad TA Jin SX Schmoll R Woolf CJ P38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia Neuron 2002, 36:57-68 10.1016/ S0896-6273(02)00908-X 12367506
142. Fjell J Cummings TR Fried K Black JA Waxman SG In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons J Neurophysiol 1999, 81:803-810 10036280
143. Mamet J Lazdunski M Voilley N How nerve growth factor drives physiological and inflammatory expression of acid-sensing ion channels 3 in sensory neurons J Biol Chem 2003, 278:48907-48913 10.1074/ jbc.M309468200 14522957
144. Petersen M Segond von Banchet G Heppelmann B Koltzenburg M Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75 Neuroscience 1998, 83:161-168 10.1016/S0306-4522(97)00374-6 9466406
145. Ramer MS Bradbury EJ McMahon SB Nerve growth factor induces P2X(3) expression in sensory neurons J Neurochem 2001, 77:864-875 10.1046/
146. Oddiah D Anand P McMahon SB Rattray M Rapid increase of NGF, BDNF and NT3 mRNAs in inflamed bladder NeuroReport 1998, 9:1455-1458 9631447 10.1097/00001756-199805110-00038
147. Miller LJ Fischer KA Goralnick SJ Litt M Burleson JA Albertsen P Kreutzer DL Nerve growth factor and chronic prostatis/chronic pelvic pain syndrome Urology 2002, 59:603-608 10.1016/S0090-4295(01)01597-7 11927336
148. Aloe L Tuveri MA Carcassi U Levi-Montalcini R Nerve growth factor in the synovial fluid of patients with chronic arthritis Arthritis Rheum 1992, 35:351-355 1536673 10.1002/art.1780350315
149. Halliday DA Zettler C Rush RA Scicchitano R McNeil JD Elevated growth factor levels in the synovial fluid of patients with inflammatory joint disease Neurochem Res 1998, 23:919-922 10.1023/A:1022475432077 9572681
150. Sarchielli P Alberti A Floridi A Gallai V Levels of nerve growth factor in cerebrospinal fluid of chronic headache patients Neurology 2001, 57:132-134 11445643
151. Andreev N Dimitrieva N Kolzenburg M McMahon SB Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones Pain 1995, 63:109-115 10.1016/0304-3959(95)00024-M 8577480
152. Apfel SC Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 2002, 50:393-413 12198818
153. Sah DWY Ossipov MH Porecca F Neurotrophic factors as novel therapeutics for neuropathic pain Nat Rev Drug Discov 2003, 2:460-472 10.1038/nrd1107 12776221
154. Owolabi JB Rizkalla G Tehim A Ross GM Riopelle RJ Kamboj R Ossipov M Bianm D Wegert S Porreca F Lee DK Characterization of antiallodynic actions ALE-0540, a novel nerve growth factor receptor antagonist, in the rat J Pharmacol Exp Ther 1999, 289:1271-1276 10336516
155. Colquhoun A Lawrance GM Shamovsky IL Riopelle RJ Ross GM Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-benzoy lamino)-4,9-dihydro-4methyl-8-oxo-pyrazolo-[5,1-b]-quinazoline-2- carboxylic acid] suggest altered NGF-p75NTR interactions in the presence of trkA J Pharmacol Exp Ther 2004, 310:505-511 10.1124/jpet.104.066225 15051797
156. Lane N Webster L Shiaoping Lu Gray M Hefti F Walicke P RN624 (anti-NGF) improves pain and function in subjects with moderate knee osteoarthritis: A phase i study Arthritis Rheum 2005, 52(Suppl): S461 10.1002/art.20791
157. Coull JA Beggs S Boudreau D Boivin D Tsuda M Inoue K Gravel C Salter MW De Koninck Y BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain Nature 2005, 438:1017-1021 10.1038/ nature04223 16355225
158. Kerr BJ Bradbury EJ Bennett DL Trivedi PM Dassan P French J Shelton DB McMahon SB Thompson SW Brain derived neurotrophic factor modulates nociceptive sensory neurone input and NMDA-evoked responses in the rat spinal cord J Neurosci 1999, 19:5138-5148 10366647
159. Deng YS Zhong JH Zhou XF Effects of endogenous neurotrophin on sympathetic sprouting in the dorsal root ganglia and allodynia following spinal nerve injury Exp Neurol 2000, 164:344-350 10.1006/exnr.2000.7432 10915573
160. Nutt JG Burchiel KJ Comella CL Jankovic J Lang AE Laws ER Jr Lozano AM Penn RD Simpson RK Jr Stacy M Wooten GF ICV GDNF Study Group. Implanted intracerebroventricular. Glial cell line-derived neurotrophic factor. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD Neurology 2003, 60:69-73 12525720
161. Welch MJ Purkiss JR Foster KA Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins Toxicon 2000, 38:245-258 10.1016/S0041-0101(99)00153-1 10665805
162. Mense S Neurobiological basis for the use of botulinum toxin in pain therapy J Neurol 2004, 251 (Suppl 1):I1-I7 10.1007/s00415-004-1102-z 14991335
163. Mahowald ML Singh JA Dykstra D Long term effects of intra-articular botulinum toxin A for refractory joint pain Neurotox Res 2006, 9:179-188 16785116
164. Apostolidis A Popat R Yiangou Y Cockyne D Ford ABDW Davis JB Dasgupta P Fowler CJ Anand P Decreased sensory receptors P2X (3) and TRPV1 in suburothelial nerve fibers following intradetrusor injection of botulinum toxin for human detrusor overactivity J Urol 2005, 174:977-982 10.1097/01.ju.0000169481.42259.54 16094018
165. D'Amour FE Smith DL A method for determining loss of pain sensation J Pharmacol Exp Ther 1941, 72:74-79
166. Woolfe G MacDonald AD The evaluation of the analgesic action of pethidine hydrochloride (Demerol) J Pharmacol Exp Ther 1944, 80:300-307
167. Le Bars D Gozariu M Cadden SW Animal models of nociception Pharmacol Rev 2001, 53:597-652 11734620
168. Felson DT Chaisson CE Hill CL Totterman SM Gale ME Skinner KM Kazis L Gale DR The association of bone marrow lesions with pain in knee osteoarthritis Ann Intern Med 2001, 134:541-549 11281736
169. Hill CL Gale DG Chaisson CE Skinner K Kazis L Gale ME Felson DT Knee effusions, popliteal cysts and synovial thickening: Association with knee pain in osteoarthritis J Rheumatol 2001, 28:1330-1337 11409127
170. Wluka AE Wolfe R Stuckey R Cicuttini FM How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis 2004, 63:264-268 1754924 14962960 10.1136/ard/2003.007666
171. Van Der Kraan OM Vitters EL van de Putte LBA van den Berg WB Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints Am J Pathol 1989, 135:1001-1014 1880494 2556924
172. Clarke KA Heitmeyer SA Smith AG Taiwo YO Gait analysis in a rat model of osteoarthritis Physiol Behav 1997, 62:951-954 10.1016/ S0031-9384(97)00022-X 9333186
173. Ivanavicius SP Ball AD Heapy CG Westwood FR Murray F Read SJ Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterization Pain 2007, 17276007
174. Bove SE Calcaterra SL Brooker RM Huber CM Guzman RE Juneau PL Schrier DJ Kilgore KS Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis Osteoarthritis Cartilage 2003, 11:821-830 10.1016/S1063-4584(03)00163-8 14609535
175. Fernihough J Gentry C Malcangio M Fox A Rediske J Pellas T Kidd B Bevan S Winter J Pain releated behaviour in two model of osteoarthritis in the rat knee Pain 2004, 112:83-93 10.1016/j.pain.2004.08.004 15494188
176. Pomonis JDM Boulet JM Gottshall SL Phillips S Rani S Bunton T Walker K Development and pharmacological characterization of a rat model of osteoarthritis pain Pain 2005, 114:339-346 10.1016/j.pain.2004.11.008 15777859